Answers are grounded in this paper and cite their sources.
Assessment reveals gaps in corticosteroid treatment for neurological diseases, highlighting future therapeutic implications.
Teoh et al. assess corticosteroid treatment regimens in autoimmune neurological disease in the light of available preclinical and clinical evidence, highlighting current gaps in the literature that are important to consider when designing future therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Teoh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: